District of Columbia Clinical Trials
Browse actively recruiting clinical trials with research sites in District of Columbia. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in District of Columbia
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaNCT06172296Ganglioneuroblastoma, NodularWashington D.C., DC
- Biospecimen Procurement for Head and Neck DisordersNCT03429036Hearing DisorderWashington D.C., DC
- Clinical and Laboratory Study of Methylmalonic AcidemiaNCT00078078Organic AcidemiaWashington D.C., DC
- A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT06667076Carcinoma, Non-Small-Cell LungWashington D.C., DC
- A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive DisorderNCT07227454Depressive Disorder, MajorWashington D.C., DC
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureNCT06742723Chronic Kidney Disease and HypertensionWashington D.C., DC
- Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialNCT06096844Advanced Lung Non-Small Cell CarcinomaWashington D.C., DC
- Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung CancerNCT06287775Extensive Stage Lung Small Cell CarcinomaWashington D.C., DC
- A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade GliomaNCT04166409Low Grade AstrocytomaWashington D.C., DC
- A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...NCT05621291B-AllWashington D.C., DC
- Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerNCT04181060Advanced Lung Non-Squamous Non-Small Cell CarcinomaWashington D.C., DC
- Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular LymphomaNCT06337318Classic Follicular LymphomaWashington D.C., DC
Popular conditions in District of Columbia
Frequently asked questions
- How do I find clinical trials in District of Columbia?
- Corterve aggregates actively recruiting clinical trials with sites in District of Columbia from the public ClinicalTrials.gov registry. Browse the studies on this page or take a free health assessment to find trials you may qualify for.
- Are clinical trials in District of Columbia free to join?
- Study participation is typically free — sponsors cover the investigational treatment and study-related visits, and many studies compensate participants for time and travel. Details vary by study.
- What kinds of clinical trials are available in District of Columbia?
- District of Columbia research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.